Abstract
Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
Yasser El Miedany, Sally S Youssef and Maha El Gaafary
The Journal of Rheumatology March 2006, 33 (3) 490-497;
Yasser El Miedany
Sally S Youssef
In this issue
Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
Yasser El Miedany, Sally S Youssef, Maha El Gaafary
The Journal of Rheumatology Mar 2006, 33 (3) 490-497;